AssayIndex
Reports by quarter

Reports submitted in 2025-Q2 · page 2

Gravimetric mass-balance reconciliation became mandatory on new records. Median purity for the quarter is 99.05 % area, n=619. Read the 2025-Q2 state-of-the-index report →

619 records16 pagesmedian on this page 99.31 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-021156IpamorelinPPGPPG-2505-U7155Janoshik2025-Q299.343.43101.2Buyer-sourced0PASS
AX-2025-018881CJC-1295 (no DAC)TFSTFS-{CAT}-9097Janoshik2025-Q299.083.64—Buyer-sourced0PASS
AX-2025-020424KPVMKMMKM-2504-N4868PeptideMeter2025-Q299.935.47—Buyer-sourced0PASS
AX-2025-0195085-Amino-1MQJEEPJEEP-2412-M9286Janoshik2025-Q299.765.07—Buyer-sourced0FAIL
AX-2025-020742TriptorelinSGNSGN-2504-A9334Medutest2025-Q298.544.2490.1Buyer-sourced1FAIL
AX-2025-020434SemaxKPKP-2502-H5248Janoshik2025-Q298.766.87—Laboratory-retained0PASS
AX-2025-020039IpamorelinSWBSWB-2501-Y7592Medutest2025-Q299.933.72—Buyer-sourced1MARGINAL
AX-2025-020031IpamorelinSWBSWB-2501-Y7592Medutest2025-Q299.743.53—Buyer-sourced1MARGINAL
AX-2025-019069AOD-9604GSPGSP-2411-L2462VendorInvestigate2025-Q298.595.1396.5Buyer-sourced0PASS
AX-2025-021071HexarelinBCHBCH-2501-B4807PeptideMeter2025-Q297.975.66105.6Buyer-sourced0FAIL
AX-2025-020855IpamorelinCPCCPC-2502-D1911Janoshik2025-Q298.714.2397.5Buyer-sourced1FAIL
AX-2025-020743TriptorelinSGNSGN-2504-A9334Janoshik2025-Q299.434.95105.6Supplier-supplied0PASS
AX-2025-019055Thymosin α1ASYASY-{CAT}-2031Medutest2025-Q299.543.99100.8Buyer-sourced0PASS
AX-2025-018928TirzepatideTFSTFS-{CAT}-9918Janoshik2025-Q296.955.21—Buyer-sourced1FAIL
AX-2025-018778GHRP-6FGPFGP-2411-J8288Medutest2025-Q299.935.58107.0Buyer-sourced1FAIL
AX-2025-018522L-Glutathione (reduced)WWBWWB-2501-L3929Medutest2025-Q299.348.36—Buyer-sourced0PASS
AX-2025-021144GHK-CuSIGSIG-2503-6560Janoshik2025-Q298.536.7791.2Buyer-sourced0PASS
AX-2025-021110L-Glutathione (reduced)BCHBCH-2502-Y5639Janoshik2025-Q297.889.15—Buyer-sourced0FAIL
AX-2025-021103RetatrutideBCHBCH-2412-Y5177Kestrel2025-Q298.343.49106.8Buyer-sourced0PASS
AX-2025-020703CJC-1295 (no DAC)SGNSGN-2412-L9210Kestrel2025-Q299.535.0590.0Buyer-sourced0PASS
AX-2025-020335TirzepatideGGPepsGGPE-2412-M2779VendorInvestigate2025-Q298.404.77—Buyer-sourced0PASS
AX-2025-020010N-Acetyl Semax AmideSWBSWB-2504-W7050Janoshik2025-Q299.439.35—Buyer-sourced0PASS
AX-2025-018658Enclomiphene citrateQSCQSC-2501-L5841Kestrel2025-Q299.936.5994.1Buyer-sourced0FAIL
AX-2025-020699CJC-1295 (no DAC)SGNSGN-2412-L9210Medutest2025-Q299.315.34107.2Buyer-sourced0PASS
AX-2025-020403TirzepatideMKMMKM-2411-B3993PeptideMeter2025-Q298.254.22101.6Buyer-sourced0PASS
AX-2025-019545CJC-1295 (no DAC)TFCTFC-2411-M9928Janoshik2025-Q299.582.57101.1Buyer-sourced0PASS
AX-2025-019338EpitalonAMBAMB-2411-X6617Janoshik2025-Q299.935.29—Buyer-sourced1FAIL
AX-2025-018695TB-500QSCQSC-2504-T6759Janoshik2025-Q299.913.60100.5Buyer-sourced1MARGINAL
AX-2025-020961TirzepatideWXTWXT-2411-F3188PeptideMeter2025-Q298.494.7896.0Laboratory-retained0PASS
AX-2025-020960TirzepatideWXTWXT-2411-F3188Janoshik2025-Q298.724.96—Buyer-sourced0PASS
AX-2025-019520GHRP-6JEEPJEEP-2503-B8635PeptideMeter2025-Q299.424.71—Buyer-sourced0PASS
AX-2025-019238AOD-9604AMBAMB-2411-S5560Janoshik2025-Q299.394.89—Laboratory-retained0PASS
AX-2025-019189TirzepatideSinoPepSNP-2411-Y4474Nordanalyt2025-Q298.293.80105.1Supplier-supplied0PASS
AX-2025-019174TB-500SinoPepSNP-2505-V3856VendorInvestigate2025-Q298.994.4795.9Buyer-sourced0PASS
AX-2025-018931TirzepatideTFSTFS-{CAT}-9918Janoshik2025-Q297.345.0788.7Buyer-sourced2MARGINAL
AX-2025-018704TB-500QSCQSC-2504-T6759PeptideMeter2025-Q299.324.19105.6Buyer-sourced1MARGINAL
AX-2025-021206TirzepatidePPGPPG-2503-R7317Janoshik2025-Q299.354.63—Buyer-sourced0PASS
AX-2025-020860MK-677 (Ibutamoren mesylate)CPCCPC-2503-G2382Janoshik2025-Q298.755.2891.0Buyer-sourced1FAIL
AX-2025-020619MK-677 (Ibutamoren mesylate)GL BiochemGLBI-2501-Y7989Nordanalyt2025-Q298.935.11—Buyer-sourced1FAIL
AX-2025-020096TirzepatideSWBSWB-2505-R8575VendorInvestigate2025-Q299.693.3591.9Buyer-sourced1MARGINAL